NCT03992144

Brief Summary

Background: One of the commonest post-operative complications after tooth extraction is dry socket; it can be defined as postoperative pain in and around the tooth extraction site, which increases in severity at any time between 3rd to 5th post-operative days along with disintegrated blood clot within the tooth extraction socket with or without halitosis. The exact etiology is unclear therefor prevention remains the main beneficial therapy. Various factors are thought to play an important role in etiology of dry socket including, anaerobes, fibrinolysis, traumatic extractions, frequent spiting and rinsing, oral contraceptive pill and smoking. Numerous approaches have been tried for prevention of dry socket; include antiseptic mouthwashes, anti-fibrinolytic agents, antibiotics, intra-socket dressings and medicated packing into the extraction wound for example chlorohexidine mouthwashes, warm saline rinses, gelatin sponges, occlusive dressings and oxidized cellulose sponge. Purpose of the study is to compare the role of single preoperative oral dose of metronidazole with amoxicillin in hindrance of dry socket compared to conventional therapy after removal of mandibular third molar of class 2 impaction. Objectives: To find out effective treatment for prevention of dry socket among preoperative single oral dose of metronidazole and amoxicillin compared to conventional therapy. Methods: A double blind randomized control trial in which patients requiring surgical extraction of lower 3rd molar of class 2 impactions were selected for this study. Patients were randomly divided into 3 groups, one of the groups had received single preoperative oral dose of metronidazole one hour before extraction, second group was treated with single oral dose of amoxicillin an hour before tooth extraction and third group was treated with conventional therapy. Patients were asked to visit on 5th postoperative day or before it in case the pain persist or reoccur.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2018

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 20, 2019

Completed
Last Updated

June 20, 2019

Status Verified

June 1, 2019

Enrollment Period

4 months

First QC Date

June 13, 2019

Last Update Submit

June 18, 2019

Conditions

Keywords

dry socketmetronidazoleamoxicillinlower 3rd molars

Outcome Measures

Primary Outcomes (1)

  • dry socket

    Characteristic of interest: patient complaining of moderate to severe pain in or around the tooth extraction site between 3 to 5 post-operative days. Measuring instruments: The observation will be performed with naked eye under the light of dental unit and cheek will be retracted via dental mirror instrument. Method of testing: Presence of moderate to severe pain, total or incomplete loss of blood clot, bare bone in the socket, and halitosis. Decision criteria: Presence of above features at the site of tooth extraction will indicate the presence of dry socket.

    5 days

Study Arms (3)

amoxicillin

EXPERIMENTAL

single preoperative oral 500 mg dose of Amoxicillin before extraction of lower 3rd molar and painkillers after extraction for 1st 48 hours then sos.

Drug: Amoxicillin 500 Mg

metronidazole

EXPERIMENTAL

single preoperative oral 400 mg dose of metronidazol before extraction of lower 3rd molar and painkillers after extraction for 1st 48 hours then sos.

Drug: metronidazole 400mg

conventional group

ACTIVE COMPARATOR

conventional therapy for prevention of dry socket post operative; 400mg metrinidazol 3 times a day for 5 days 500mg of amooxicillin 2 times a day for 5 days painkiller 48 hours after extraction then sos

Drug: metronidazol 400mg and amoxicillin 500mg

Interventions

Amoxicillin 500mg an hour before tooth extraction

Also known as: amoxill 500mg
amoxicillin

400mg of metronidazole an hour before extraction

Also known as: flygel 400mg
metronidazole

400mg metronidazole TDS, amoxicillin 500mg BD for 5 days after extraction

conventional group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients requiring surgical extraction of lower third molars with class 2 impaction.
  • Males and females were included.
  • Age range of the patients was between 18 to 40 years.

You may not qualify if:

  • Non-surgical extractions, extractions of other then lower molars,
  • Infected tooth.
  • tooth with grade 3 or greater mobility.
  • Reluctant to participate.
  • Pregnant ladies.
  • Nursing mothers.
  • Alcoholic patients.
  • Smokers.
  • Patients taking oral contraceptives.
  • Patient already taking antibiotics.
  • Allergic to amoxicillin and metronidazole.
  • Patients on anticoagulant therapy i.e. warfarin, nicoumalone, phenytoin, fluocil.
  • Those with severe renal and hepatic dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dow University of Health Sciences

Karachi, Sindh, Pakistan

Location

MeSH Terms

Conditions

Dry Socket

Interventions

AmoxicillinMetronidazoleBenchmarking

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

AmpicillinPenicillin GPenicillinsbeta-LactamsLactamsAmidesOrganic ChemicalsSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsNitroimidazolesNitro CompoundsImidazolesAzolesHeterocyclic Compounds, 1-RingManagement AuditOrganization and AdministrationHealth Services AdministrationProgram EvaluationQuality of Health CareQuality Assurance, Health CareHealth Care Quality, Access, and EvaluationHealth Care Evaluation Mechanisms

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
postgraduate trainee

Study Record Dates

First Submitted

June 13, 2019

First Posted

June 20, 2019

Study Start

October 1, 2018

Primary Completion

January 31, 2019

Study Completion

April 15, 2019

Last Updated

June 20, 2019

Record last verified: 2019-06

Locations